Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Hoosier Cancer Research Network
NRG Oncology
NRG Oncology
NRG Oncology
Mayo Clinic
Novartis
Assistance Publique - Hôpitaux de Paris
Avera McKennan Hospital & University Health Center
RasCal Therapeutics, Inc.
Filamon LTD
University Hospital Heidelberg
UMC Utrecht
Shanghai Chest Hospital
University of California, Davis
Essen Biotech
Memorial Sloan Kettering Cancer Center
Second Affiliated Hospital of Nanchang University
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Mayo Clinic
University of Washington
City of Hope Medical Center
Degron Therapeutics Co.
University Health Network, Toronto
Servier
Sun Yat-sen University
Dana-Farber Cancer Institute
Massive Bio, Inc.
Latin American Cooperative Oncology Group
LigaChem Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Guangzhou JOYO Pharma Co., Ltd
Apollomics Inc.
Columbia University
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
Second Affiliated Hospital of Guangzhou Medical University
Xiangya Hospital of Central South University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Shanghai Yunying Medical Technology
Hospices Civils de Lyon